课题基金 / 基金详情

Exploiting a Bacterial Nano-Syringe for Protein Therapeutics

Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
批准号:
7656802
负责人:
Charles Erec Stebbins
金额:
$33.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2011-07-31

项目摘要

项目成果

Charles Erec Stebbins的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The great promise of nanotechnology is the development of "molecular machines" for a myriad of uses, and especially within biomedicine. Extensive efforts are underway to design and produce such machines from a variety of elements and first principles. We propose to take a "reverse-engineering" approach to this problem by exploiting a molecular machine that has evolved within the microbial world, a bacterial protein injection system called the "molecular syringe." This device has evolved in pathogenic bacteria to precisely deliver protein toxins into human cells, and therefore functions as a "nano-syringe," converting energy into the work of protein injection. We plan to use this injection device to deliver into diseased cells functional versions of eukaryotic proteins that have been mutated or otherwise rendered non-functional in the illness, as well as proteins and peptides that may inhibit the action of malfunctioning proteins. Examples include restoring functional tumor suppressors or pro-apoptotic polypeptides into transformed lines, injecting enzymes mutated in inherited diseases, and adding inhibitors of transcription to achieve a desired shut down in certain genes whose expression leads to pathology. Should these goals be realized, we will have learned to harness an amazing bacterial nano-machine for biomedical applications, providing a new and powerful tool for treating a potentially broad range of diseases. Project Narrative: We propose to adapt a bacterial protein injection system to precisely deliver protein and peptide therapeutics into diseased human cells Examples include restoring functional tumor suppressors or pro-apoptotic polypeptides into transformed lines, injecting enzymes mutated in inherited diseases, and adding inhibitors of transcription to achieve a desired shut down in certain genes whose expression leads to pathology. Should these goals be realized, we will have learned to harness this amazing bacterial nano- machine for biomedical applications, providing a new and powerful tool for treating a potentially broad range of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interactions of Helicobacter pylori CagA with Host Factors
  • 批准号:
    8352946
  • 项目类别:
  • 资助金额:
    $21.19万
  • 财政年份:
    2012
  • 负责人:
    Charles Erec Stebbins
  • 依托单位:
Assembly and Function of the Bacterial Type III Secretion System Basal Body
  • 批准号:
    8535920
  • 项目类别:
  • 资助金额:
    $42.38万
  • 财政年份:
    2012
  • 负责人:
    Charles Erec Stebbins
  • 依托单位:
Interactions of Helicobacter pylori CagA with Host Factors
  • 批准号:
    8503595
  • 项目类别:
  • 资助金额:
    $23.9万
  • 财政年份:
    2012
  • 负责人:
    Charles Erec Stebbins
  • 依托单位:
H PYLORI CAGA INHIBITS PAR1-MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
  • 批准号:
    8361570
  • 项目类别:
  • 资助金额:
    $0.26万
  • 财政年份:
    2011
  • 负责人:
    Charles Erec Stebbins
  • 依托单位:
海外基金